March 10, 2023 06:52 AM ESTUpdated 08:21 AM
Peer Review

Bio­gen looks to its bench to re­place chair­man Pa­padopou­los; Lil­ly, Ab­b­Vie gene ther­a­py part­ner makes CSO hire

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Car­o­line Dor­sa will chair the board at Bio­gen af­ter its an­nu­al meet­ing in June, the com­pa­ny re­vealed on Wednes­day. Last …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times